2nd Taiwan COVID vaccine maker to apply for EUA on Phase 2 data
Taipei, June 27 (CNA) Taiwanese vaccine maker United Biomedical Inc. (UBI) Asia announced Sunday that it will seek emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate before the end of June after unveiling the interim results of its Phase 2 clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
China's provocation against Taiwan 'deeply destabilizing:' Blinken05/27/2022 12:42 AM
France selected as theme country at Taipei book fair for the fourth time05/27/2022 12:26 AM
COVID-19 death rate exceeding 0.1 percent a warning: health minister05/26/2022 11:36 PM
Self-health management rule for migrant workers to be relaxed from Friday05/26/2022 11:33 PM
Taiwan freedivers compete under 'Taiwan' at Caribbean Cup after protesting05/26/2022 10:09 PM